Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders

doi:10.1155/2018/6929732

CNU IR > The Centers > The Center For General Education > Periodical Articles > Item 310902800/32220

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/32220

Title:	Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders
Authors:	Chen, Pei-Hao Cheng, Shih-Jung Lin, Hui-Chi Lee, Chuo-Yu Chou, Chih-Ho
Contributors:	MacKay Mem Hosp, Dept Neurol Mackay Med Coll, Dept Med Natl Taipei Univ Technol, Grad Inst Mech & Elect Engn Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol Tamkang Univ, Grad Inst Chem Chi Mei Med Ctr, Dept Neurol Chia Nan Univ Pharm & Sci
Keywords:	Alzheimers Association Workgroups Society Task-Force Diagnostic Guidelines National Institute Clinical Dementia Older-Adults Disease Recommendations Management Decline
Date:	2018
Issue Date:	2019-11-15 15:45:40 (UTC+8)
Publisher:	HINDAWI LTD
Abstract:	Objective. Mild cognitive impairment (MCI) is a transitional state between normal aging and early dementia. It has a heterogeneous etiology and clinical course. This study aimed to examine the factors associated with the progression of MCI in different types of dementia disorders. Method. A retrospective, longitudinal, observational study of outpatients with MCI was conducted at a medical center in northern Taiwan. Patient medical records were reviewed, and risk factors were analyzed by multivariate analysis. Results. Among 279 patients with MCI, 163 (58.4%), 68 (24.4%), and 48 (17.2%) were diagnosed with Alzheimer's disease, vascular cognitive impairment, and Lewy body diseases, respectively. During the observation period, 37.2% of patients progressed to dementia. Older age and a higher Clinical Dementia Rating Scale-Sum of Boxes were associated with the risk of progression. Hyperlipidemia was associated with a decreased risk. Converters were more likely to receive an antidementia prescription. Conclusion. Our study suggests the importance of comprehensive clinical profiling, risk factor assessment, and detailed drug history evaluations in improving our understanding and management of dementia subtypes.
???metadata.dc.relation.uri???:	http://dx.doi.org/10.1155/2018/6929732
Relation:	Cell Biochemistry and Biophysics, v.2018, ID 6929732
Appears in Collections:	[The Center For General Education] Periodical Articles

Files in This Item:

File	Description	Size	Format
10.1155-2018-6929732.pdf		1561Kb	Adobe PDF	428	View/Open
index.html		0Kb	HTML	1680	View/Open

Loading...